Expression of Heat Shock Protein 70 Modulates the Chemoresponsiveness of Pancreatic Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Heat shock protein (HSP) 70 is constitutively overexpressed in pancreatic cancer cells (PCCs) and appears to confer protection against chemotherapeutics. We investigated whether modulating HSP 70 increases chemoresponsiveness to gemcitabine in PCCs. Methods: Varying concentrations of quercetin and gemcitabine, either alone or in combination, were added to PCCs (Panc-1 and Mia-PaCa-2). MTT assay was performed to analyze cell viability. HSP 70 expression was assessed by Western blot analysis. Apoptosis was determined by measuring caspase-3 activity. Western blot for the LC3-II protein detected the presence of autophagy. Results: HSP 70 levels were not affected by the incubation of Panc-1 and MiaPaCa-2 cells with gemcitabine,whereas with quercetin, the levels were reduced in both cell lines. The viability of both Panc-1 and MiaPaCa-2 cells significantly decreased with gemcitabine treatment but not with quercetin. A combination of gemcitabine and quercetin decreased the viability of both cell lines in a dose-dependent manner, which was more pronounced than gemcitabine treatment alone. Treatment with either gemcitabine or quercetin augmented caspase-3 activity in both cell lines,and a combination of these compounds further potentiated caspase-3 activity. LC3-II protein expression was negligible with gemcitabine treatment but marked with quercetin. The addition of gemcitabine to quercetin did not potentiate LC3-II protein expression. Conclusions: Modulation of HSP 70 expression with quercetin enhanced the chemoresponsiveness of PCCs to gemcitabine. The mechanism of cell death was both apoptosis and autophagy
Abstract
Background/Aims: Heat shock protein (HSP) 70 is constitutively overexpressed in pancreatic cancer cells (PCCs) and appears to confer protection against chemotherapeutics. We investigated whether modulating HSP 70 increases chemoresponsiveness to gemcitabine in PCCs. Methods: Varying concentrations of quercetin and gemcitabine, either alone or in combination, were added to PCCs (Panc-1 and Mia-PaCa-2). MTT assay was performed to analyze cell viability. HSP 70 expression was assessed by Western blot analysis. Apoptosis was determined by measuring caspase-3 activity. Western blot for the LC3-II protein detected the presence of autophagy. Results: HSP 70 levels were not affected by the incubation of Panc-1 and MiaPaCa-2 cells with gemcitabine,whereas with quercetin, the levels were reduced in both cell lines. The viability of both Panc-1 and MiaPaCa-2 cells significantly decreased with gemcitabine treatment but not with quercetin. A combination of gemcitabine and quercetin decreased the viability of both cell lines in a dose-dependent manner, which was more pronounced than gemcitabine treatment alone. Treatment with either gemcitabine or quercetin augmented caspase-3 activity in both cell lines,and a combination of these compounds further potentiated caspase-3 activity. LC3-II protein expression was negligible with gemcitabine treatment but marked with quercetin. The addition of gemcitabine to quercetin did not potentiate LC3-II protein expression. Conclusions: Modulation of HSP 70 expression with quercetin enhanced the chemoresponsiveness of PCCs to gemcitabine. The mechanism of cell death was both apoptosis and autophagy
참고문헌 (35)
- Hariharan D, "Analysis of mortality rates for pancreatic cancer across the world", HPB (Oxford), 10, pp.58~62 (2008)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007", Journal of Korean Medical Science, 25(8), pp.1113~1121 (2010), 대한의학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008", Cancer Research and Treatment, 43(1), pp.1~11 (2011), 대한암학회
- Jemal A, "Cancer statistics, 2010", CA Cancer J Clin, 60, pp.277~300 (2010)
- Neoptolemos JP, "A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer", N Engl J Med, 350, pp.1200~1210 (2004)
- Yeo CJ, "Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes", Ann Surg, 226, pp.248~257 (1997)
- Loehrer PJ Sr, "Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial", J Clin Oncol, 29, pp.4105~4112 (2011)
- Burris HA 3rd, "Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial", J Clin Oncol, 15, pp.2403~2413 (1997)
- Rothenberg ML, "New developments in chemotherapy for patients with advanced pancreatic cancer", Oncology (Williston Park), 10(9 Suppl), pp.18~22 (1996)
- Moore MJ, "Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group", J Clin Oncol, 25, pp.1960~1966 (2007)
- Bold RJ, "Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content", Ann Surg Oncol, 6, pp.279~285 (1999)
- Huang P, "Induction of apoptosis by gemcitabine", Semin Oncol, 22(4 Suppl 11), pp.19~25 (1995)
- Sliutz G, "Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy", Br J Cancer, 74, pp.172~177 (1996)
- Wong HR, "Heat shock proteins. Facts, thoughts, and dreams. A. De Maio", Shock, 12, pp.323~325 (1999)
- Dudeja V, "The role of heat shock proteins in gastrointestinal diseases", Gut, 58, pp.1000~1009 (2009)
- Feng JY, "Alteration and role of heat shock proteins in acute pancreatitis", J Dig Dis, 11, pp.277~283 (2010)
- Ethridge RT, "Acute pancreatitis results in induction of heat shock proteins 70 and 27 and heat shock factor-1", Pancreas, 21, pp.248~256 (2000)
- Aghdassi A, "Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma", Cancer Res, 67, pp.616~625 (2007)
- Phillips PA, "Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70", Cancer Res, 67, pp.9407~9416 (2007)
- Dudeja V, "Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms", Gastroenterology, 136, pp.1772~1782 (2009)
- Nylandsted J, "Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization", J Exp Med, 200, pp.425~435 (2004)
- Mosser DD, "The chaperone function of hsp70 is required for protection against stress-induced apoptosis", Mol Cell Biol, 20, pp.7146~7159 (2000)
- Stankiewicz AR, "Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation", J Biol Chem, 280, pp.38729~38739 (2005)
- Beere HM, "Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome", Nat Cell Biol, 2, pp.469~475 (2000)
- Guo F, "Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells", Blood, 105, pp.1246~1255 (2005)
- Czaja MJ, "Functions of autophagy in hepatic and pancreatic physiology and disease", Gastroenterology, 140, pp.1895~1908 (2011)
- Kondo Y, "Autophagy and cancer therapy", Autophagy, 2, pp.85~90 (2006)
- Todde V, "Autophagy: principles and significance in health and disease", Biochim Biophys Acta, 1792, pp.3~13 (2009)
- Adachi S, "Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines", Int J Hyperthermia, 25, pp.210~219 (2009)
- Nanbu K, "Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas", Cancer Detect Prev, 22, pp.549~555 (1998)
- Ciocca DR, "Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications", J Natl Cancer Inst, 85, pp.570~574 (1993)
- Ralhan R, "Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix", Clin Cancer Res, 1, pp.1217~1222 (1995)
- Kalogeraki A, "HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes", Anticancer Res, 26(5A), pp.3551~3554 (2006)
- Santarosa M, "Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients", Eur J Cancer, 33, pp.873~877 (1997)
- Trieb K, "Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy", Hum Pathol, 29, pp.1050~1055 (1998)